首页> 外文期刊>Evidence-based complementary and alternative medicine: eCAM >Evaluation of Antimalarial Activity of the Leaf Latex and TLC Isolates from Aloe megalacantha Baker in Plasmodium berghei Infected Mice
【24h】

Evaluation of Antimalarial Activity of the Leaf Latex and TLC Isolates from Aloe megalacantha Baker in Plasmodium berghei Infected Mice

机译:叶片麦芽糖贝克在疟原虫疟原虫感染小鼠中评价叶片乳胶和TLC分离物的抗疟疾活性

获取原文
获取外文期刊封面目录资料

摘要

Malaria is a devastating parasitic disease which caused around 216 million cases and 445,000 deaths worldwide in 2016. This might be attributed to a wide spread of drug resistant parasites. The plant Aloe megalacantha is indigenous to Ethiopia where the sap of the leaves is traditionally used for the treatment of malaria. This study was aimed at evaluating the antimalarial effect of leaf latex and isolates obtained from Aloe megalacantha against chloroquine sensitive Plasmodium berghei ANKA strain in Swiss albino mice. Peters’ 4-day suppressive test method was used to test the antimalarial activity of both leaves latex and isolates. Three isolates were obtained using thin layer chromatography and were coded as AM1, AM2, and AM3 in ascending order of their retention factor. After treatment of Plasmodium berghei infected mice with leaf latex of Aloe megalacantha for four days at 100, 200, and 400?mg/kg, it shows 30.3%, 43.4%, and 56.4% suppression of the parasite growth, respectively. 32.3%, 51.3%, and 67.4% chemosuppression after treatment with AM1, 39.8%, 50.6%, and 64.2% chemosuppression after treatment with AM2, and 52.6%, 69.4%, and 79.6% chemosuppression after treatment with AM3 were observed at doses of 100, 200, and 400?mg/kg/day, respectively. The observed parasite suppression of leaves latex and isolates was statistically significant (P0.05) as compared to negative control. Moreover, both the leaves latex and isolates were also observed to prevent Plasmodium berghei induced body weight loss and hypothermia and increased the survival time of Plasmodium berghei infected mice as compared to the negative control. Hence, the present study supports the traditional claim of the plant for the treatment of malaria.
机译:疟疾是2016年造成约21600万个案件和全球445,000人死亡的令人革命的寄生虫疾病。这可能归因于耐药寄生虫的广泛蔓延。植物芦荟巨大的埃塞俄比亚是埃塞俄比亚的土着,其中叶子的SAP传统上用于治疗疟疾。本研究旨在评估叶乳胶乳胶和分离株的抗疟疾效果,从瑞士白化小鼠中对芦荟麦加拉氏菌抗氯喹敏疟原菌氏菌菌株。彼得斯的4天抑制试验方法用于测试两种叶子乳胶和分离物的抗疟疾活性。使用薄层色谱法获得三个分离株,并以保留因子的升序编码为AM1,AM2和AM3。在100,200和400×Mg / kg的芦荟乳胶叶乳胶乳胶乳胶乳胶乳胶的疟原虫乳胶(Permodium Permodium)小鼠中分别显示出30.3%,43.4%和56.4%的寄生虫生长。在用AM2处理后,在am1,39.8%,50.6%和64.2%化学抑制后,在用am3处理后,在am2和64.2%的化学抑制后,32.3%,51.3%和67.4%化学抑制抑制剂100,200和400?mg / kg /天。与阴性对照相比,观察到的寄生虫抑制叶片胶乳和分离物的抑制性统计学意义(P <0.05)。此外,还观察到叶片胶乳和分离物,以防止苯乙烯诱导的体重减轻和体温过低,并且与阴性对照相比,苯乙烯受感染小鼠的疟原虫的存活时间增加。因此,本研究支持植物治疗疟疾的传统索赔。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号